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Identification and Linkage to Care of HCV-Infected Persons in Five Health
Centers — Philadelphia, Pennsylvania, 2012–2014
Catelyn Coyle, MPH1, Kendra Viner, PhD2, Elizabeth Hughes, DrPH3, Helena Kwakwa, MD2, Jon E. Zibbell, PhD3, Claudia Vellozzi, MD3,
Deborah Holtzman, PhD3 (Author affiliations at the end of text)

Approximately three million persons in the United States are
infected with hepatitis C virus (HCV), a blood-borne pathogen
that is an increasing cause of liver disease and mortality in the
United States (1,2). Treatments for HCV are curative, of short
duration, and have few associated side effects (3), increasing
the importance of identifying HCV-infected persons. Many
persons with HCV infection were infected decades ago, before
implementation of prevention measures and most are unaware
of their infection, regardless of when it occurred (4). Most
newly diagnosed cases are associated with injection drug use
(5). Persons born during 1945–1965 have a fivefold higher
risk of HCV infection than other adults and the highest risk
for HCV-related morbidity and mortality (6). CDC recommends testing for this group, for persons who inject drugs, and
others at risk for HCV infection (6,7). From October 2012
through July 2014, the National Nursing Centers Consortium
(NNCC) carried out a project to integrate routine HCV testing
and linkage-to-care in five federally qualified health centers in
Philadelphia, PA, that primarily serve homeless persons and
public housing residents. During the project period, 4,514
patients across the five centers were tested for HCV. Of these,
595 (13.2%) were HCV-antibody positive and 550 (92.4%)
had a confirmatory HCV-RNA test performed. Of those who
had a confirmatory HCV-RNA test performed, 390 (70.9%)
were identified as having current (i.e., chronic) HCV infection
(overall prevalence = 8.6%). Of those currently infected with
HCV, 90% were informed of their status, 78% were referred to
an HCV care specialist, and 62% went to the referred specialist
for care. Replicable system modifications that improved HCV
testing and care included enhancements to electronic medical
records (EMRs), simplification of HCV testing protocols, and
addition of a linkage-to-care coordinator. Findings from this
project highlight the need for innovative strategies for HCV
testing, care, and treatment, as well as the important role of
community health centers in expanding access for patient
populations disproportionately affected by HCV infection (1).
In 2012, the NNCC, a national membership organization
functioning to advance nurse-led care, partnered with its parent
company, Public Health Management Corporation (PHMC)*,
* The Public Health Management Corporation (PHMC) is a nonprofit public
health institute that builds healthier communities through partnerships with
government, foundations, businesses and community-based organizations
(additional information available at http://www.phmc.org/site/index.php).

to implement routine HCV testing and referral to care in
PHMC’s five federally qualified health centers (FQHCs) in
Philadelphia, PA: 1) Mary Howard Health Center (exclusively
serving homeless patients); 2) Rising Sun Health Center and
3) PHMC Health Connection (both family medicine clinics
serving public housing residents); 4) Congreso Health Center
(serving primarily Hispanic patients); and 5) PHMC Care Clinic
(offering primary care and specialized health services to patients
with unmet medical and social needs, including treatment for
patients with human immunodeficiency virus (HIV) and HCV
infection). All of these health centers integrated routine HCV
testing through a medical assistant-initiated, opt-out, laboratorybased model with EMR modifications to prompt, track, report,
and facilitate reimbursement for HCV tests.
Before testing began, the NNCC project manager and a
local hepatitis C expert trained clinic personnel on HCV disease etiology, effects, and testing goals. The project manager
assisted clinic staff with integrating testing into the existing
clinic infrastructure to minimize disruption in routine services.
Informational posters were placed in each health center to
educate patients on prevalence, risk factors for HCV infection
and recommendations for who should be tested. Patients eligible for testing included those born during 1945–1965 (i.e.,
“Baby Boomers”), those with other risks for HCV infection
(e.g., injection drug use) (6,7), and those who were homeless.
An automatic electronic reminder, (the first of four EMR
enhancements), identified patients eligible for testing based
on birth year. Mary Howard Health Center and PHMC Care
Clinic tested all patients, because most of those seen at these
two clinics were assumed to be at increased risk for HCV infection. At the other three sites, medical assistants interviewed
patients and tested those with at least one identified risk factor
for HCV infection.
Medical assistants notified patients that they would be tested
for HCV unless they opted out. For patients who verbally
agreed to be tested, a standing order was in place to initiate the
requisition for HCV-antibody with reflex to an HCV-RNA
test to detect current HCV infection. With reflex testing, the
laboratory uses the same specimen to perform an HCV-RNA
test on any positive HCV-antibody test specimen, thus eliminating the need for a second blood specimen to be collected
from the patient. NNCC negotiated competitive pricing with
commercial laboratories to perform HCV tests on uninsured
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patients and an account was created and added to the EMR
(second EMR enhancement). Selecting this account generated
a separate invoice specifically for HCV tests performed on
uninsured patients.
Weekly reports showing the number of patients, by health
center, who were tested and the names of those whose results
were HCV-antibody-positive and HCV-RNA-positive were
generated by the EMR (third EMR enhancement). These
reports were sent to the project manager who provided the
information to the clinic directors, medical assistants, and
linkage-to-care coordinator. The latter assisted all patients
who were HCV-antibody-positive through the care process,
which included providing all current HCV-infected patients
with their test results, offering onsite posttest counseling,
and referring patients to HCV-care specialists (primary-care
providers trained to care for patients infected with HCV, as
well as hepatologists or gastroenterologists from one of the
local academic medical centers) for medical evaluation. An
automatic reminder was generated by the EMR (final EMR
enhancement) alerting health-care providers that an HCVinfected patient was eligible for linkage-to-care services, such
as an escort to follow-up medical appointments, transportation reimbursements, reminder phone calls, and appointment
scheduling. This report reflects data extracted from the EMR
that was shared across all five health centers.
From October 1, 2012 through July 31, 2014, a total of
4,514 patients were tested for HCV across the five FQHCs;
595 (13.2%) had a positive HCV-antibody test result (Table).
Among the HCV-antibody positive-patients, 550 (92.4%)
had an HCV-RNA test performed and of these, 390 (70.9%)
were identified with current HCV infection, for an overall
prevalence of 8.6%. Most HCV-infected patients were male,
non-Hispanic black, and had public insurance compared
with others in these demographic subgroups. Although nonHispanic blacks accounted for a greater proportion of persons
with current infection than non-Hispanic whites (53.6% versus
29.5%), non-Hispanic whites had a greater overall prevalence
of HCV infection compared with non-Hispanic blacks (21.1%
versus 7.3%). Baby Boomers accounted for 62.6% of patients
with current HCV infection. Among 352 patients reporting
drug use, 205 (58.2%) reported having injected drugs in
their lifetime. The two clinics conducting HCV testing for
all patients, without ascertainment of risk (the PHMC Care
Clinic and the Mary Howard Health Center), performed a
greater number of tests compared with the other sites and had
the highest proportion of patients who were HCV-antibodypositive and currently infected. Of the 390 persons with current HCV infection, 348 (89.2%) received their HCV-RNA
positive results, 304 (78.0%) were referred to an HCV-care
specialist for medical evaluation, and 240 (61.5%) were seen
460
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by the specialist (Figure). Of the 390 patients with current
HCV infection, 25 (6.4%) began antiviral treatment during
the data collection period of this project. The PHMC Care
Clinic identified 247 HCV-infected patients and successfully
linked 167 (67.6%) to medical care. Among the five FQHCs,
the PHMC Care Clinic had the highest rates of linkage to care.
During the course of the project, HCV testing and care for
patients at the FQHCs improved, as the result of a change
in HCV-RNA test availability and additional system modifications. In March 2013, all commercial laboratories began
conducting reflex testing. Before this, testing for HCV-RNA
was more cumbersome, requiring a second blood specimen be
obtained at the same or at a subsequent visit. In the 5 months
before reflex testing was routinely available, only 83.6% of
the clinics’ patients with positive HCV antibody tests received
confirmatory testing. From March through July 2013, early
in the transition to reflex testing, this percentage increased to
84.8%. However, by July 2014, as use of the reflex test became
more routinely used, the percentage of HCV-antibody-positive
patients who received confirmatory testing increased to 96.3%.
Another system modification initiated during the project was
a change from provider-initiated testing to medical assistantinitiated testing at the PHMC Care Clinic. At the beginning
of the project, a nurse identified and reminded providers (with
a chart note) of patients who were eligible for testing and the
need to order an HCV test. An EMR prompt to identify Baby
Boomers also was in place at this time. However, the process
proved time intensive and inefficient: in clinics serving large
patient populations with complex needs, chart notes were
often overlooked and nurses had many other responsibilities.
Medical assistant-initiated HCV testing resulted in a 6.3%
increase in testing from an observation period of 11 months
before compared with 11 months after implementing this
procedural modification.
Beginning in September 2013, through funding from a
public-private partnership, annual HIV testing for patients
aged ≥13 years was implemented in the health centers, at which
time the HCV testing protocol was modified to include HIV
testing. Dual testing substantially increased the total number
of HCV tests performed. A total of 1,786 HCV tests were
performed during the 11-month project period leading up
to this modification, whereas from September 2013 through
July 2014, a total of 2,728 HCV tests were performed, representing a 52.7% increase.
A final modification that led to improved patient care was
the addition of a linkage-to-care coordinator position. This
coordinator was responsible for providing intensive services,
including contacting patients who did not keep their appointments and addressing any barriers to care (e.g., affordable
transportation). Between the 11 months before the addition
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TABLE. Number, percentage, and prevalence of patients tested for HCV, and identified as HCV-antibody positive and currently infected*, by
demographic characteristics and health centers† — Philadelphia PA, October 2012–July 2014
HCV-Antibody Tested
Characteristic
Sex
Male
Female
Race/Ethnicity
Non-Hispanic Black
Non-Hispanic White
Hispanic
Asian
Other
Missing
Birth Year Cohort
<1945
1945–1965
>1965
Health Insurance Type
Uninsured
Public Insurance
Private Insurance
Health Center
Care Clinic
Mary Howard
PHMC Health
Connection
Rising Sun
Congreso
Total

Currently Infected§

HCV-Antibody Positive

(%)††

Prevalence§§ (%)

297
93

(76.2)
(23.8)

(11.8)
(4.7)

(10.8)
(31.7)
(11.2)
(3.7)
(2.6)
(14.7)

209
115
48
5
1
12

(53.6)
(29.5)
(12.3)
(1.3)
(0.3)
(3.1)

(7.3)
(21.1)
(6.6)
(3.7)
(1.3)
(7.1)

(0.3)
(61.5)
(38.2)

(3.8)
(19.4)
(8.8)

2
244
144

(0.5)
(62.6)
(36.9)

(3.8)
(12.9)
(5.6)

126
433
36

(21.2)
(72.8)
(6.1)

(8.4)
(16.0)
(11.4)

77
290
23

(19.7)
(74.4)
(5.9)

(5.2)
(10.7)
(7.3)

(33.6)
(23.9)
(18.5)

358
159
31

(60.2)
(26.7)
(5.2)

(23.6)
(14.7)
(3.7)

247
108
11

(63.3)
(27.7)
(2.8)

(16.3)
(10.0)
(1.3)

(17.9)
(6.0)
(100)

24
23
595

(4.0)
(3.9)
(100)

(3.0)
(8.5)
(13.2)

12
12
390

(3.1)
(3.1)
(100)

(1.5)
(4.4)
(8.6)

No.

(%)

No.

(%)¶

Prevalence** (%)

2,522
1,992

(55.9)
(44.1)

421
174

(70.8)
(29.2)

(16.7)
(8.7)

2,862
545
724
136
77
170

(63.4)
(12.1)
(16.0)
(3.0)
(1.7)
(3.8)

309
173
81
5
2
25

(51.9)
(29.1)
(13.6)
(0.8)
(0.3)
(4.2)

53
1,890
2,571

(1.2)
(41.9)
(57.0)

2
366
227

1,495
2,704
315

(33.1)
(59.9)
(7.0)

1,518
1,079
837
808
272
4,514

No.

Abbreviation: HCV = hepatitis C virus
* Currently infected indicates a diagnosis of chronic infection with HCV based on positive results of HCV-RNA testing.
† Health centers are five federally qualified health centers owned and managed by the Public Health Management Corporation, Philadelphia, PA.
§ 550 (92.4%) of 595 persons with HCV-antibody positive tests received HCV-RNA testing.
¶ Percent positive among those tested.
** Percent positive among those tested in each demographic subgroup and health center.
†† Percent currently infected among those tested.
§§ Percent currently infected among those tested in each demographic subgroup.

of the position and 11 months afterwards, these services
increased the number of HCV-infected patients who received
their positive HCV-RNA test results by 67.7% (from 130 to
218 patients); patient referrals by 49.2% (from 122 to 182);
and the number of patients seen by an HCV care specialist by
28.6% (from 105 to 135).
Discussion

This project demonstrated that routine HCV testing can be
successfully integrated into ambulatory care settings providing services for persons disproportionately affected by HCV
infection. The project introduced six practices that could be
replicated in other clinical settings. First, it tasked medical
assistants with guiding patients through the HCV testing
process, relieving the burden on clinicians and other health
center staff. Second, reflex HCV testing technology was used
to ensure that HCV-antibody positive patients received HCVRNA testing necessary to detect current HCV infection. Such
testing also allowed patients to receive test results and care
referrals in one visit. Third, test costs associated with patients

without insurance were eliminated as a barrier to testing.
Fourth, modifying the HCV testing protocol to include HIV
testing led to substantial increases in the number of HCV tests
performed and currently infected patients identified (82.6%
increase). Because more patients were eligible for HIV testing,
the HCV test was easily added to the laboratory requisition.
Fifth, EMR modifications also improved patient care. The
EMR prompted testing and the need for linkage-to-care services, all of which were monitored by the project manager and
the linkage-to-care coordinator. Weekly reports tracked testing
and patient progression through the HCV care continuum.
EMR modifications also simplified the payment process for
HCV tests performed on uninsured patients. Finally, intensive
services carried out by the linkage-to-care coordinator increased
the number of currently infected patients who received their
results and were referred and seen by a specialist. This effort
ensured that more patients received appropriate posttest
counseling and medical evaluation for liver health and HCV
treatment initiation.
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confirmatory testing might not have met
laboratory testing requirements because of
insufficient quantity or improper handling.
100
Providers might have inadvertently ordered the
§
Total
90
hepatitis panel that currently only includes an
Average†
HCV-antibody test.
80
Linkage-to-care rates also were higher than
70
those observed in Philadelphia surveillance
60
data (9), an outcome likely attributed to
50
creation of the linkage-to-care coordinator
40
position. Initially, linkage services included
reminder phone calls, public transportation
30
tokens for patients to attend appointments,
20
or patient escorts. However, some patients
10
were found to require additional services. The
0
linkage-to-care coordinator provided intensive
Seen by
Chronically
Received
Referred to
support services: following up with patients
specialist
infected
RNA+ result
specialist**
who did not keep appointments; conduct(N = 304)
(N = 240)
(N = 390)
(N = 348)
ing off-site (e.g., home, shelters, and halfway
Stage of care
houses) visits as necessary; acting as an intermeAbbreviation: RNA+ = Patients whose specimens tested positive for HCV.
diary point of contact between the patient and
* Patients with chronic HCV infection are defined as those who are currently infected with HCV based
the FQHCs; and helping identify and resolve
upon a positive result to HCV-RNA test.
† All five FQHCs are owned and managed by Philadelphia-based Public Health Management Corporation.
any barriers patients experienced in attending
§ Error bars are the range of percentages for each stage of care across all five FQHCs.
appointments. These services fostered trusting
¶ Average = average of values at all five FQHCs.
relationships with patients. Additionally, the
** Specialists include primary care providers who were trained to care for patients infected with HCV,
as well as hepatologists or gastroenterologists from one of the local academic medical centers.
linkage-to-care coordinator remained a point
of contact for HCV-infected patients that had
fallen out of care because of addiction, unstable housing, or
The project successfully targeted patients at high risk for
distrust of health care systems. The linkage-to-care coordinator
HCV infection; overall 8.6% of patients were infected with
worked with these patients until they were ready to reengage
HCV, a higher proportion than previous estimates. Only 1%
in care, linked them to social and addiction support programs,
(0.8%–1.2%) of the general U.S. population is estimated to be
and provided specialized care plans to ensure they attended
infected with HCV (1). A geographically targeted communitytheir HCV medical appointments. Similar intensive linkage
based testing program also carried out in Philadelphia found
services in community-based HCV testing and linkage-tothat 2.8% of persons were estimated to be living with current
care programs in Philadelphia also have proven successful in
HCV infection (8). The percentage of patients receiving an
navigating HCV-infected patients into care (8).
HCV-RNA test confirming their current infection status
The most successful linkage-to-care rates were seen at the
likewise was higher (92% versus 47%) than that reported by
PHMC Care Clinic, where HCV testing, care, and treatment
the Philadelphia Department of Public Health from routine
are provided in the same setting. This test-and-treat model
surveillance of viral hepatitis (9). The higher percentage in this
eliminates the need to refer patients to an outside care proproject is largely attributable to the use of reflex testing (10),
vider, except in extenuating circumstances (e.g., a patient with
which ensures that a greater number of persons are tested for
advanced liver disease or cirrhosis). Because of the high number
current infection and can learn their infection status without
of HCV-infected patients seen there, the Mary Howard Health
returning to provide a second blood specimen.
Center plans to expand its services to include on-site HCV treatA relatively small proportion of HCV-antibody-positive
ment. Linkage-to-care rates were lowest at health centers serving
patients (7.6%) did not receive a confirmatory test during the
patients at low risk of HCV infection. Because they served fewer
project period. There are several possible reasons for this. Some
HCV-infected patients, providers at these sites might not be as
patients submitted specimens early in the project, before the
aware of the HCV linkage-to-care protocol. To increase rates in
implementation of reflex testing, and might not have returned
these settings, HCV protocols will be updated and included in
for confirmatory HCV-RNA test. Specimens submitted for
an automated centralized forum accessible by staff for training.
Percentage

FIGURE. Contiuum of care process for patients with chronic hepatitis C (HCV) infection*
treated at five federally qualified health centers (FQHCs)† — Philadelphia, PA, October
2012–July 2014
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What is already known about this topic?
Hepatitis C virus (HCV) infection is a major cause of chronic liver
disease and hepatocellular carcinoma and the leading indication
for liver transplantation in the United States. Approximately three
million persons in the United States are infected with HCV, and
many are unaware of their status and are diagnosed late. As
persons disproportionately affected by HCV (e.g., poor, homeless,
born during 1945-1965, injection drug users) age, HCV-related
morbidity, mortality, and spending are expected to increase.
What is added by this report?
Routine HCV testing and linkage-to-care for persons with
current infection were successfully integrated into five federally
qualified health centers in Philadelphia, PA. Across the centers,
595 (13.2%) of 4,514 patients tested were HCV-antibody positive
and 550 (92.4%) received HCV-RNA testing. Of the 390 (70.9%)
with current (chronic) HCV infection, 348 (89.2%) received their
results, 304 (78.0%) were referred to and 240 (61.5%) were seen
by a provider familiar with HCV care and treatment. This project
demonstrated the feasibility of identifying low-income persons
living with HCV infection and linking them to care.
What are the implications for public health practice?
In collaboration with public health agencies and other service
providers, community health centers are optimally positioned
to play a pivotal role in expanding access to recommended HCV
testing, care, and treatment for populations disproportionately
affected by hepatitis C. Delivering HCV-related care via trusted
healthcare professionals, with the addition of embedded and
intensive support services, at primary care settings can increase
successful outcomes at every stage of the care continuum.

There were two main limitations of this project. The first was
its relatively small size. HCV testing and linkage to care were
integrated into a small network of health centers and therefore
the practices and lessons learned from the project may not be
applicable to larger settings, such as a large hospital system, or
in other geographic areas. To address this, NNCC is exploring
ways to replicate this model in larger health center networks
in other cities. Second, the duration of the project did not
follow patients through HCV treatment to cure. NNCC is
working with offices of local HCV providers to collect data
on treatment history and clinical outcomes.
The high rate of HCV infection among persons in disproportionately affected populations, like those seen at the

five FQHCs, indicates a need for innovative models that can
identify persons with HCV infection and ensure they receive
appropriate care. Delivering care via trusted health care professionals at primary care settings can improve outcomes at every
stage of the continuum of care, from reflex testing to providing
timely test results and linking patients to HCV-focused care.
In collaboration with public health agencies and other service
providers, community health centers are optimally positioned
to play an important role in expanding access to recommended
HCV testing, care, and treatment for populations disproportionately affected by hepatitis C.
1National Nursing Centers Consortium; 2Philadelphia Department of Public
Health; 3Division of Viral Hepatitis, CDC
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